Compile Data Set for Download or QSAR
Report error Found 136 Enz. Inhib. hit(s) with Target = 'Nuclear receptor subfamily 2 group E member 1'
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50130262(2,3,4,9-Tetrahydro-1H-beta-carboline | CHEMBL26923...)
Affinity DataEC50:  7.40E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50404775(CHEMBL31888)
Affinity DataEC50:  1.94E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50580566(CHEMBL3304960)
Affinity DataEC50:  6.70E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM14777(CHEMBL779 | (6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-m...)
Affinity DataEC50:  5.00E+3nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataEC50:  3.20E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50067133(CHEMBL631 | 1-[2-(2-Hydroxy-3-propylamino-propoxy)...)
Affinity DataEC50:  4.70E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM60973(MLS001333595 | (2R)-1-(1-naphthalenyloxy)-3-(propa...)
Affinity DataEC50:  4.00E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50246936(S-(-)-propanolol | (-)-(S)-Propranolol | [2-Hydrox...)
Affinity DataEC50:  7.20E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50580567(CHEMBL5070124)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50580568(CHEMBL5088115)
Affinity DataEC50:  8.30E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50580569(CHEMBL5083628)
Affinity DataEC50:  5.20E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50061966(Isopropyl-[3-(naphthalen-1-yloxy)-propyl]-amine | ...)
Affinity DataEC50:  5.00E+4nMAssay Description:Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured afte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataEC50:  3.20E+4nMAssay Description:Agonist activity at full length TLX activating element expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as dec...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50130262(2,3,4,9-Tetrahydro-1H-beta-carboline | CHEMBL26923...)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50404775(CHEMBL31888)
Affinity DataEC50:  4.30E+4nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50580566(CHEMBL3304960)
Affinity DataEC50: >1.00E+5nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataEC50:  3.70E+4nMAssay Description:Agonist activity at TAE expressed in human HEK293T cells coexpressing human full-length TLX/Gal4-VP 16 assessed as renilla luciferase reporter activi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM25761(Propanolol,(+/-) | PROPRANOLOL, l- | PROPRANOLOL,(...)
Affinity DataKd:  500nMAssay Description:Binding affinity to TLX LBD expressed in His6-tagged Escherichia coli Rosetta assessed as binding constant measured after 300 sec at 200 mM by isothe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584383(CHEMBL5080162 | EN300-5601139)
Affinity DataEC50:  2.00E+4nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584384(CHEMBL5090226 | US20240067625, Compound 30)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584385(CHEMBL5077720)
Affinity DataEC50:  1.10E+4nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584386(CHEMBL5071695)
Affinity DataEC50:  5.00E+3nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584387(CHEMBL5088898)
Affinity DataEC50:  3.00E+3nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584388(CHEMBL5089826)
Affinity DataEC50:  1.20E+3nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584389(CHEMBL5080383)
Affinity DataEC50:  251nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584383(CHEMBL5080162 | EN300-5601139)
Affinity DataEC50:  2.00E+4nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584389(CHEMBL5080383)
Affinity DataEC50:  250nMAssay Description:Agonist activity at human Gal4-fused TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP16 assessed as repressor activity of receptor by me...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584389(CHEMBL5080383)
Affinity DataEC50:  700nMAssay Description:Agonist activity at human full length Gal4-fused TLX transfected in human HEK293T cells coexpressing pFR-TAE-Luc assessed as repressor activity of re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584389(CHEMBL5080383)
Affinity DataKd:  1.60E+3nMAssay Description:Binding affinity to recombinant TLX LBD (unknown origin) by differential scanning fluorometryMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584389(CHEMBL5080383)
Affinity DataEC50:  5.00E+3nMAssay Description:Agonist activity at TLX (unknown origin) assessed as induction of receptor oligomerization using sGFP-labeled TLX LBD as acceptor and biotin TLX LBD ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2023
Entry Details Article
PubMed
TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655798(US20240067625, Compound 1)
Affinity DataEC50:  0.0510nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655799(US20240067625, Compound 2)
Affinity DataEC50:  0.102nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655800(US20240067625, Compound 3)
Affinity DataEC50:  0.0280nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655801(US20240067625, Compound 4)
Affinity DataEC50:  0.0300nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655798(US20240067625, Compound 1)
Affinity DataEC50:  0.0850nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655799(US20240067625, Compound 2)
Affinity DataEC50:  0.0640nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655800(US20240067625, Compound 3)
Affinity DataEC50:  0.0280nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655801(US20240067625, Compound 4)
Affinity DataEC50:  0.0300nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655802(US20240067625, Compound 29)
Affinity DataEC50:  0.0360nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM50584384(CHEMBL5090226 | US20240067625, Compound 30)
Affinity DataEC50:  0.0670nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655804(US20240067625, Compound 31)
Affinity DataEC50:  0.0140nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655805(US20240067625, Compound 32)
Affinity DataEC50:  0.0140nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655806(US20240067625, Compound 33)
Affinity DataEC50:  0.0190nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655807(US20240067625, Compound 35)
Affinity DataEC50:  0.0130nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655808(US20240067625, Compound 36)
Affinity DataEC50:  0.0130nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655809(US20240067625, Compound 37)
Affinity DataEC50:  0.0340nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655810(US20240067625, Compound 39)
Affinity DataEC50:  0.0280nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655811(US20240067625, Compound 40)
Affinity DataEC50:  0.0530nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655812(US20240067625, Compound 41)
Affinity DataEC50:  0.00600nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

TargetNuclear receptor subfamily 2 group E member 1(Human)
Goethe-University Frankfurt

Curated by ChEMBL
LigandPNGBDBM655813(US20240067625, Compound 43)
Affinity DataEC50:  6.91E+3nMAssay Description:Assays were performed according to the manufacturer's protocol (PerkinElmer, USA), with the following modifications: Ligands were tested for TLX-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 136 total ) | Next | Last >>
Jump to: